Sofosbuvir/Ledipasvir Compound Drugs Market Report

Global and Region Sofosbuvir/Ledipasvir Compound Drugs Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：143
  • REPORT CODE：GMM935873
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Sofosbuvir/Ledipasvir Compound Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Sofosbuvir/Ledipasvir Compound Drugsmarket, defines the market attractiveness level of Sofosbuvir/Ledipasvir Compound Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Sofosbuvir/Ledipasvir Compound Drugs industry, describes the types of Sofosbuvir/Ledipasvir Compound Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Sofosbuvir/Ledipasvir Compound Drugs market and the development prospects and opportunities of Sofosbuvir/Ledipasvir Compound Drugs industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Sofosbuvir/Ledipasvir Compound Drugs market in Chapter 13.

    By Player:

    • Zydus Cadila

    • Lupin Ltd

    • Natco Ltd

    • Sun Pharmaceutical Industries

    • Cipla

    • Abbott

    • Gilead Sciences

    • Biocon

    • Hetero Drugs

    • Dr Reddy's Laboratories

    • Torrent Pharmaceuticals

    By Type:

    • Bottled Packaging

    • Film Coated Packaging

    By End-User:

    • Hepatitis C Virus (HCV) Genotype 1

    • Hepatitis C Virus (HCV) Genotype 3

    • Hepatitis C Virus (HCV) Genotype 4

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Sofosbuvir/Ledipasvir Compound Drugs Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Sofosbuvir/Ledipasvir Compound Drugs Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Sofosbuvir/Ledipasvir Compound Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Sofosbuvir/Ledipasvir Compound Drugs Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Sofosbuvir/Ledipasvir Compound Drugs Market Analysis and Outlook to 2022

    • 7.1 Global Sofosbuvir/Ledipasvir Compound Drugs Consumption (2017-2022)

    • 7.2 United States Sofosbuvir/Ledipasvir Compound Drugs Consumption (2017-2022)

    • 7.3 Europe Sofosbuvir/Ledipasvir Compound Drugs Consumption (2017-2022)

    • 7.4 China Sofosbuvir/Ledipasvir Compound Drugs Consumption (2017-2022)

    • 7.5 Japan Sofosbuvir/Ledipasvir Compound Drugs Consumption (2017-2022)

    • 7.6 India Sofosbuvir/Ledipasvir Compound Drugs Consumption (2017-2022)

    • 7.7 South Korea Sofosbuvir/Ledipasvir Compound Drugs Consumption (2017-2022)

    8 Region and Country-wise Sofosbuvir/Ledipasvir Compound Drugs Market Analysis and Outlook to 2028

    • 8.1 Global Sofosbuvir/Ledipasvir Compound Drugs Consumption Forecast (2022-2028)

    • 8.2 United States Sofosbuvir/Ledipasvir Compound Drugs Consumption Forecast (2022-2028)

    • 8.3 Europe Sofosbuvir/Ledipasvir Compound Drugs Consumption Forecast (2022-2028)

    • 8.4 China Sofosbuvir/Ledipasvir Compound Drugs Consumption Forecast (2022-2028)

    • 8.5 Japan Sofosbuvir/Ledipasvir Compound Drugs Consumption Forecast (2022-2028)

    • 8.6 India Sofosbuvir/Ledipasvir Compound Drugs Consumption Forecast (2022-2028)

    • 8.7 South Korea Sofosbuvir/Ledipasvir Compound Drugs Consumption Forecast (2022-2028)

    9 Global Sofosbuvir/Ledipasvir Compound Drugs Market Outlook by Types and Applications to 2022

    • 9.1 Global Sofosbuvir/Ledipasvir Compound Drugs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Bottled Packaging Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Film Coated Packaging Consumption and Growth Rate (2017-2022)

    • 9.2 Global Sofosbuvir/Ledipasvir Compound Drugs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hepatitis C Virus (HCV) Genotype 1 Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Hepatitis C Virus (HCV) Genotype 3 Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Hepatitis C Virus (HCV) Genotype 4 Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Sofosbuvir/Ledipasvir Compound Drugs Market Outlook by Types and Applications to 2028

    • 10.1 Global Sofosbuvir/Ledipasvir Compound Drugs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Bottled Packaging Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Film Coated Packaging Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Sofosbuvir/Ledipasvir Compound Drugs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hepatitis C Virus (HCV) Genotype 1 Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Hepatitis C Virus (HCV) Genotype 3 Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Hepatitis C Virus (HCV) Genotype 4 Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Sofosbuvir/Ledipasvir Compound Drugs Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Sofosbuvir/Ledipasvir Compound Drugs Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Sofosbuvir/Ledipasvir Compound Drugs Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Sofosbuvir/Ledipasvir Compound Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Sofosbuvir/Ledipasvir Compound Drugs Market Competitive Analysis

    • 14.1 Zydus Cadila

      • 14.1.1 Zydus Cadila Company Details

      • 14.1.2 Zydus Cadila Sofosbuvir/Ledipasvir Compound Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Zydus Cadila Sofosbuvir/Ledipasvir Compound Drugs Product and Service

    • 14.2 Lupin Ltd

      • 14.2.1 Lupin Ltd Company Details

      • 14.2.2 Lupin Ltd Sofosbuvir/Ledipasvir Compound Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Lupin Ltd Sofosbuvir/Ledipasvir Compound Drugs Product and Service

    • 14.3 Natco Ltd

      • 14.3.1 Natco Ltd Company Details

      • 14.3.2 Natco Ltd Sofosbuvir/Ledipasvir Compound Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Natco Ltd Sofosbuvir/Ledipasvir Compound Drugs Product and Service

    • 14.4 Sun Pharmaceutical Industries

      • 14.4.1 Sun Pharmaceutical Industries Company Details

      • 14.4.2 Sun Pharmaceutical Industries Sofosbuvir/Ledipasvir Compound Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Sun Pharmaceutical Industries Sofosbuvir/Ledipasvir Compound Drugs Product and Service

    • 14.5 Cipla

      • 14.5.1 Cipla Company Details

      • 14.5.2 Cipla Sofosbuvir/Ledipasvir Compound Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Cipla Sofosbuvir/Ledipasvir Compound Drugs Product and Service

    • 14.6 Abbott

      • 14.6.1 Abbott Company Details

      • 14.6.2 Abbott Sofosbuvir/Ledipasvir Compound Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Abbott Sofosbuvir/Ledipasvir Compound Drugs Product and Service

    • 14.7 Gilead Sciences

      • 14.7.1 Gilead Sciences Company Details

      • 14.7.2 Gilead Sciences Sofosbuvir/Ledipasvir Compound Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Gilead Sciences Sofosbuvir/Ledipasvir Compound Drugs Product and Service

    • 14.8 Biocon

      • 14.8.1 Biocon Company Details

      • 14.8.2 Biocon Sofosbuvir/Ledipasvir Compound Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Biocon Sofosbuvir/Ledipasvir Compound Drugs Product and Service

    • 14.9 Hetero Drugs

      • 14.9.1 Hetero Drugs Company Details

      • 14.9.2 Hetero Drugs Sofosbuvir/Ledipasvir Compound Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Hetero Drugs Sofosbuvir/Ledipasvir Compound Drugs Product and Service

    • 14.10 Dr Reddy's Laboratories

      • 14.10.1 Dr Reddy's Laboratories Company Details

      • 14.10.2 Dr Reddy's Laboratories Sofosbuvir/Ledipasvir Compound Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Dr Reddy's Laboratories Sofosbuvir/Ledipasvir Compound Drugs Product and Service

    • 14.11 Torrent Pharmaceuticals

      • 14.11.1 Torrent Pharmaceuticals Company Details

      • 14.11.2 Torrent Pharmaceuticals Sofosbuvir/Ledipasvir Compound Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Torrent Pharmaceuticals Sofosbuvir/Ledipasvir Compound Drugs Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Sofosbuvir/Ledipasvir Compound Drugs

    • Figure Sofosbuvir/Ledipasvir Compound Drugs Picture

    • Table Global Sofosbuvir/Ledipasvir Compound Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Sofosbuvir/Ledipasvir Compound Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Sofosbuvir/Ledipasvir Compound Drugs Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Sofosbuvir/Ledipasvir Compound Drugs Consumption by Country (2017-2022)

    • Figure United States Sofosbuvir/Ledipasvir Compound Drugs Consumption and Growth Rate (2017-2022)

    • Table Europe Sofosbuvir/Ledipasvir Compound Drugs Consumption and Growth Rate (2017-2022)

    • Figure China Sofosbuvir/Ledipasvir Compound Drugs Consumption and Growth Rate (2017-2022)

    • Figure Japan Sofosbuvir/Ledipasvir Compound Drugs Consumption and Growth Rate (2017-2022)

    • Figure India Sofosbuvir/Ledipasvir Compound Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Korea Sofosbuvir/Ledipasvir Compound Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Sofosbuvir/Ledipasvir Compound Drugs Consumption Forecast by Country (2022-2028)

    • Figure United States Sofosbuvir/Ledipasvir Compound Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Sofosbuvir/Ledipasvir Compound Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Sofosbuvir/Ledipasvir Compound Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Sofosbuvir/Ledipasvir Compound Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Sofosbuvir/Ledipasvir Compound Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Sofosbuvir/Ledipasvir Compound Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Bottled Packaging Consumption and Growth Rate (2017-2022)

    • Figure Global Film Coated Packaging Consumption and Growth Rate (2017-2022)

    • Figure Global Hepatitis C Virus (HCV) Genotype 1 Consumption and Growth Rate (2017-2022)

    • Figure Global Hepatitis C Virus (HCV) Genotype 3 Consumption and Growth Rate (2017-2022)

    • Figure Global Hepatitis C Virus (HCV) Genotype 4 Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Bottled Packaging Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Film Coated Packaging Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hepatitis C Virus (HCV) Genotype 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hepatitis C Virus (HCV) Genotype 3 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hepatitis C Virus (HCV) Genotype 4 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Sofosbuvir/Ledipasvir Compound Drugs Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Sofosbuvir/Ledipasvir Compound Drugs Export by Region (Top 5 Countries) (2017-2028)

    • Table Zydus Cadila (Foundation Year, Company Profile and etc.)

    • Table Zydus Cadila Sofosbuvir/Ledipasvir Compound Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Zydus Cadila Sofosbuvir/Ledipasvir Compound Drugs Product and Service

    • Table Lupin Ltd (Foundation Year, Company Profile and etc.)

    • Table Lupin Ltd Sofosbuvir/Ledipasvir Compound Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lupin Ltd Sofosbuvir/Ledipasvir Compound Drugs Product and Service

    • Table Natco Ltd (Foundation Year, Company Profile and etc.)

    • Table Natco Ltd Sofosbuvir/Ledipasvir Compound Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Natco Ltd Sofosbuvir/Ledipasvir Compound Drugs Product and Service

    • Table Sun Pharmaceutical Industries (Foundation Year, Company Profile and etc.)

    • Table Sun Pharmaceutical Industries Sofosbuvir/Ledipasvir Compound Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sun Pharmaceutical Industries Sofosbuvir/Ledipasvir Compound Drugs Product and Service

    • Table Cipla (Foundation Year, Company Profile and etc.)

    • Table Cipla Sofosbuvir/Ledipasvir Compound Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cipla Sofosbuvir/Ledipasvir Compound Drugs Product and Service

    • Table Abbott (Foundation Year, Company Profile and etc.)

    • Table Abbott Sofosbuvir/Ledipasvir Compound Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Sofosbuvir/Ledipasvir Compound Drugs Product and Service

    • Table Gilead Sciences (Foundation Year, Company Profile and etc.)

    • Table Gilead Sciences Sofosbuvir/Ledipasvir Compound Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gilead Sciences Sofosbuvir/Ledipasvir Compound Drugs Product and Service

    • Table Biocon (Foundation Year, Company Profile and etc.)

    • Table Biocon Sofosbuvir/Ledipasvir Compound Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biocon Sofosbuvir/Ledipasvir Compound Drugs Product and Service

    • Table Hetero Drugs (Foundation Year, Company Profile and etc.)

    • Table Hetero Drugs Sofosbuvir/Ledipasvir Compound Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hetero Drugs Sofosbuvir/Ledipasvir Compound Drugs Product and Service

    • Table Dr Reddy's Laboratories (Foundation Year, Company Profile and etc.)

    • Table Dr Reddy's Laboratories Sofosbuvir/Ledipasvir Compound Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dr Reddy's Laboratories Sofosbuvir/Ledipasvir Compound Drugs Product and Service

    • Table Torrent Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Torrent Pharmaceuticals Sofosbuvir/Ledipasvir Compound Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Torrent Pharmaceuticals Sofosbuvir/Ledipasvir Compound Drugs Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US